Histone Modifications in Cancer Biology and Prognosis

作者: Siavash K. Kurdistani

DOI: 10.1007/978-3-7643-8989-5_5

关键词: EpigeneticsGeneHistoneCancer cellRegulation of gene expressionCancer researchChromatinHuman genomeCancerBiology

摘要: Cancer is a disease of genome sequence alterations as well epigenetic changes. Epigenetics refers in part to the mechanisms by which histones affect various DNA-based processes, such gene regulation. Histones are proteins around DNA wraps itself form chromatin – physiologically relevant human genome. modified extensively posttranslational modifications that alter structure and serve recruit or exclude protein complexes from DNA. Aberrations histone occur frequently cancer including changes their levels distribution at promoters, coding regions, repetitive sequences, other genomic elements. Locus-specific may have adverse effects on expression nearby genes but so far not been shown clinical utility. cells also exhibit global specific modifications, generating an additional layer heterogeneity cellular level tumor tissues. Unlike locus-specific changes, can be used define previously unrecognized subsets patients with distinct outcomes. In general, increased prevalence lower prognostic poorer outcome risk recurrence and/or decreased survival probability. Prognostic utility has demonstrated independently for multiple cancers those prostate, lung, kidney, breast, ovary, pancreas, suggesting fundamental association between modification aggressiveness, regardless tissue origin. Cellular predict response certain chemotherapeutic agents, serving predictive biomarkers could inform decisions choice course therapy. The challenge before us understand how established maintained what mechanistic links behavior.

参考文章(171)
Andrew J. Bannister, Robert Schneider, Tony Kouzarides, Histone methylation: dynamic or static? Cell. ,vol. 109, pp. 801- 806 ,(2002) , 10.1016/S0092-8674(02)00798-5
Jacqueline J. L. Jacobs, Karin Kieboom, Silvia Marino, Ronald A DePinho, Maarten van Lohuizen, The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus Nature. ,vol. 397, pp. 164- 168 ,(1999) , 10.1038/16476
Andrew J. Bannister, Philip Zegerman, Janet F. Partridge, Eric A. Miska, Jean O. Thomas, Robin C. Allshire, Tony Kouzarides, Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature. ,vol. 410, pp. 120- 124 ,(2001) , 10.1038/35065138
Jianxin Ye, Xi Ai, Ericka E. Eugeni, Liwen Zhang, Laura Rocco Carpenter, Mary A. Jelinek, Michael A. Freitas, Mark R. Parthun, Histone H4 Lysine 91 Acetylation: A Core Domain ModificationAssociated with Chromatin Assembly Molecular Cell. ,vol. 18, pp. 123- 130 ,(2005) , 10.1016/J.MOLCEL.2005.02.031
Carine Van Lint, Stephane Emiliani, Eric Verdin, The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expression. ,vol. 5, pp. 245- 253 ,(1996)
Monika Lachner, Dónal O'Carroll, Stephen Rea, Karl Mechtler, Thomas Jenuwein, Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. ,vol. 410, pp. 116- 120 ,(2001) , 10.1038/35065132
Christophe Dhalluin, Justin E. Carlson, Lei Zeng, Cheng He, Aneel K. Aggarwal, Ming-Ming Zhou, Ming-Ming Zhou, Structure and ligand of a histone acetyltransferase bromodomain Nature. ,vol. 399, pp. 491- 496 ,(1999) , 10.1038/20974
Maria Vogelauer, Jiansheng Wu, Noriyuki Suka, Michael Grunstein, Global histone acetylation and deacetylation in yeast Nature. ,vol. 408, pp. 495- 498 ,(2000) , 10.1038/35044127
Hilal Özdağ, Andrew E Teschendorff, Ahmed Ashour Ahmed, Sarah J Hyland, Cherie Blenkiron, Linda Bobrow, Abhi Veerakumarasivam, Glynn Burtt, Tanya Subkhankulova, Mark J Arends, V Peter Collins, David Bowtell, Tony Kouzarides, James D Brenton, Carlos Caldas, None, Differential expression of selected histone modifier genes in human solid cancers BMC Genomics. ,vol. 7, pp. 90- 90 ,(2006) , 10.1186/1471-2164-7-90